A Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for Efficient Capture of Essential Data from a Patient and a Health Professional in a Uniform "Scientific" Format

Rheumatic Disease Clinics of North America

Volumn 35, Issue 4, 2009, Pages 843-850

  Pincus, Theodore ^a   Callahan, Leigh F ^b   Sokka, Tuulikki ^c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Database; Joint count; Questionnaire; Standard protocol to evaluate rheumatoid arthritis (SPERA)

Indexed keywords

COMORBIDITY; COMPUTER PROGRAM; DEATH; HUMAN; INFORMATION PROCESSING; LABORATORY TEST; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MORTALITY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REVIEW; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VISUAL ANALOG SCALE;

ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; HEALTH STATUS; HUMANS; JOINTS; PHYSICAL EXAMINATION; QUESTIONNAIRES;

EID: 70949106359     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.10.016     Document Type: Review

References (39)

1. Tugwell P., Wells G., Strand V., et al. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide rheumatoid arthritis investigators group. Arthritis Rheum 43 (2000) 506-514
2. Pincus T., Callahan L.F., Sale W.G., et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27 (1984) 864-872
3. Wolfe F., and Cathey M.A. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 18 (1991) 1298-1306
4. Callahan L.F., Bloch D.A., and Pincus T. Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 45 (1992) 127-138
5. Wolfe F., and Hawley D.J. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 25 (1998) 2108-2117
6. Sokka T., Kautiainen H., Möttönen T., et al. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 26 (1999) 1681-1685
7. Lubeck D.P., Spitz P.W., Fries J.F., et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 29 (1986) 488-493
8. Wolfe F., and Zwillich S.H. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 41 (1998) 1072-1082
9. Wolfe F., Kleinheksel S.M., Cathey M.A., et al. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 15 (1988) 1480-1488
10. Leigh J.P., and Fries J.F. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 18 (1991) 1307-1312
11. Pincus T., Brooks R.H., and Callahan L.F. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 120 (1994) 26-34
12. Callahan L.F., Cordray D.S., Wells G., et al. Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale scores. Arthritis Care Res 9 (1996) 463-472
13. Callahan L.F., Pincus T., Huston III J.W., et al. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 10 (1997) 381-394
14. Söderlin M.K., Nieminen P., and Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 25 (1998) 1895-1899
15. Sokka T., Hakkinen A., Krishnan E., et al. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 63 (2004) 494-497
16. Sokka T., Abelson B., and Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26 (2008) S35-S61
17. Kvien T.K., Glennås A., Knudsrod O.G., et al. The validity of self-reported diagnosis of rheumatoid arthritis: results from a population survey followed by clinical examinations. J Rheumatol 23 (1996) 1866-1871
18. Mitchell J.M., Burkhauser R.V., and Pincus T. The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 31 (1988) 348-357
19. Pincus T., Brooks R.H., and Callahan L.F. A proposed standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes. J Relig 26 (1999) 473-480
20. Pincus T., and Sokka T. A three-page Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from patients and health professionals in standard clinical care and clinical research. Best Pract Res Clin Rheumatol 21 (2007) 677-685
21. Fuchs H.A., Brooks R.H., Callahan L.F., et al. A simplified twenty-eight joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 32 (1989) 531-537
22. Fuchs H.A., Kaye J.J., Callahan L.F., et al. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16 (1989) 585-591
23. Pincus T., Callahan L.F., Brooks R.H., et al. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 110 (1989) 259-266
24. Sokka T., and Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. J Rheumatol 30 (2003) 1138-1146
25. Sokka T., and Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum 48 (2003) 313-318
26. Pincus T., Sokka T., and Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 32 (2005) 1432-1439
27. Sokka T., Kautiainen H., Toloza S., et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66 (2007) 1491-1496
28. Sokka T., Toloza S., Cutolo M., et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther 11 (2009) R7
29. Sokka T., Kautiainen H., Pincus T., et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 68 (2009) 1666-1672
30. Fries J.F., Spitz P., Kraines R.G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
31. Pincus T., Bergman M.J., Yazici Y., et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 47 (2008) 345-349
32. Pincus T., Swearingen C.J., Bergman M., et al. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to DAS and CDAI categories. J Rheumatol 35 (2008) 2136-2147
33. Fries J.F. Time-oriented patient records and a computer databank. JAMA 222 (1972) 1536-1542
34. Fries J.F. Editorial: a data bank for the clinician?. N Engl J Med 294 (1976) 1400-1402
35. Wolfe F., Lassere M., van der Heijde D., et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 26 (1999) 484-489
36. Parkerson Jr. G.R., Broadhead W.E., and Tse C.K.J. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol 46 (1993) 379-393
37. Katz J.N., Chang L.C., Sangha O., et al. Can comorbidity be measured by questionnaire rather than medical record review?. Med Care 34 (1996) 73-84
38. Cleves M.A., Sanchez N., and Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 50 (1997) 903-908
39. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383